echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Merck will split into two companies

    Merck will split into two companies

    • Last Update: 2020-02-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On February 5, MSD released its Q4 and full year financial report in 2019, and announced a major news that it has decided to split MSD into two growth companies! MSD said it would spin off the franchises of women's health, patent brands and bio similar drugs and set up an independent listed company Kenneth C Frazier, chairman and CEO of MSD, announced the news, saying that by optimizing MSD's human health product portfolio, MSD could be closer to the company's goal of becoming a leading R & D-based biopharmaceutical company In today's financial report, we can see that in 2019, the annual sales of MSD reached 46.8 billion US dollars, of which the annual sales of keytruda, a heavy product in the field of cancer, reached 11.1 billion US dollars, an increase of 55%.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.